查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866534

自体输血装置市场－2025-2030年预测

Auto Transfusion Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

自体输血设备市场预计将从 2025 年的 6.2225 亿美元成长到 2030 年的 8.3389 亿美元，复合年增长率为 6.03%。

受全球心血管疾病发生率上升的推动，自体输血装置市场正经历显着成长。世界卫生组织（WHO）的数据显示，心血管疾病每年导致约1,790万人死亡，占全球死亡总数的31%。这些装置用于在手术过程中采集并回输患者自身的血液，从而降低感染疾病传播的风险，并消除同种异体致敏的风险，因此得到了广泛应用。此外，开发中国家医疗保健投入的增加也透过改善先进医疗技术的可近性，推动了市场扩张。

本报告检验了自体输血设备市场当前的需求、供应和销售趋势，以及影响该市场发展的最新动态。报告全面分析了关键驱动因素、限制因素和机会，并深入探讨了不同地区的行业趋势、政策和法规，使相关人员能够深入了解法律规范和影响市场环境的关键因素。

我们的竞争情报是基于广泛的二手资料研究，旨在识别主要企业及其收入贡献。资讯来源包括产业协会分析、分析师报告、投资者报告、新闻稿和学术期刊。我们采用自下而上和自上而下的方法计算了自体输血设备行业及其主要细分市场的市场规模。相关数据已透过国际自体输血设备价值链相关人员的第一手资讯进行检验。我们全面的市场分析整合了多种资讯来源和专有资料集，并运用资料三角验证法，以提供准确的市场区隔和预测。

本报告运用分析说明、图表和图形，深入剖析全球自体输血设备市场的动态。报告分析了各类设备类型和技术的需求，包括术中、术后和急诊自体输血系统，以及在医院、门诊手术中心和专科诊所的应用领域。此外，报告还分析了技术进步、政府政策、法规结构和宏观经济因素。

本报告为业内专业人士提供关于市场趋势、监管环境和竞争动态的关键洞察。报告重点阐述了心血管疾病发病率上升和医疗基础设施投资（尤其是在发展中地区）带来的成长机会。报告采用严谨的分析方法，结合一手和二手数据，确保提供可靠的洞察，帮助相关人员应对复杂的监管环境、竞争压力和投资重点，从而在一个对透过创新血液管理解决方案改善手术效果和病患安全至关重要的市场中做出明智的决策。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 自体输血装置市场：依类型划分

  • 介绍
  • 手术过程中
  • 术后

第五章 自体输血装置市场：依应用划分

  • 介绍
  • 心血管外科
  • 整形外科手术
  • 神经外科
  • 器官移植
  • 其他的

第七章 按终端用户产业分類的自体输血设备市场

  • 介绍
  • 医院
  • 门诊手术中心
  • 其他的

第八章 自体输血装置市场：依地区划分

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Medline Industries, LP
  • Medtronic plc
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • LivaNova
  • Atrium Medical
  • BD
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

第十一章 分析方法

简介目录
Product Code: KSI061611959

The Auto Transfusion Devices Market is set to increase from USD 622.250 million in 2025 to USD 833.890 million by 2030, registering a 6.03% CAGR.

The autotransfusion devices market is experiencing significant growth, driven by the rising global prevalence of cardiovascular diseases, which, according to the World Health Organization, account for approximately 17.9 million deaths annually, or 31% of global mortality. These devices, used to collect and reinfuse a patient's own blood during surgical procedures, are increasingly adopted due to their ability to reduce the risk of infectious disease transmission and eliminate isosensitization risks. Additionally, growing healthcare investments in developing countries bolster market expansion by enhancing access to advanced medical technologies.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the autotransfusion devices market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and critical factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall autotransfusion devices sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global autotransfusion devices value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global autotransfusion devices market dynamics. The report explores demand across various device types and technologies, including intraoperative, postoperative, and emergency autotransfusion systems, as well as applications in hospitals, ambulatory surgical centers, and specialty clinics. It also investigates technological advancements, government policies, regulatory frameworks, and macroeconomic factors.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights growth opportunities driven by the increasing burden of cardiovascular diseases and healthcare infrastructure investments, particularly in developing regions. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate regulatory complexities, competitive pressures, and investment priorities in a market vital to improving surgical outcomes and patient safety through innovative blood management solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

  • Intraoperative
  • Postoperative

By Application

  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurology Surgery
  • Organ Transplantation
  • Others

By End-User Industry

  • Hospitals
  • Ambulatory Surgery Centres
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AUTO TRANSFUSION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Interoperative
  • 5.3. Postoperative

5. AUTO TRANSFUSION DEVICES MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Cardiovascular Surgery
  • 5.3. Orthopedic Surgery
  • 5.4. Neurology Surgery
  • 5.5. Organ Transplantation
  • 5.5. Others

7. AUTO TRANSFUSION DEVICES MARKET BY END-USER INDUSTRY

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgery Centres
  • 7.4. Others

8. AUTO TRANSFUSION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indosneisa
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medline Industries, LP
  • 10.2. Medtronic plc
  • 10.3. Haemonetics Corporation
  • 10.4. Fresenius Kabi AG
  • 10.5. Terumo Corporation
  • 10.6. LivaNova
  • 10.7. Atrium Medical
  • 10.8. BD
  • 10.9. Stryker Corporation
  • 10.10. Zimmer Biomet Holdings, Inc.

11. RESEARCH METHODOLOGY